Calian Group (TSE:CGY) Price Target Raised to C$82.00

Calian Group (TSE:CGY) had its target price lifted by Ventum Financial from C$72.00 to C$82.00 in a report released on Friday morning,BayStreet.CA reports. They currently have a buy rating on the stock.

Several other research analysts also recently weighed in on CGY. Acumen Capital boosted their target price on Calian Group from C$70.00 to C$85.00 and gave the stock a “buy” rating in a research note on Friday. Canaccord Genuity Group boosted their target price on shares of Calian Group from C$63.00 to C$80.00 in a research report on Friday. Canadian Imperial Bank of Commerce upped their price target on shares of Calian Group from C$65.00 to C$76.00 in a research note on Friday. Royal Bank Of Canada boosted their price objective on shares of Calian Group from C$58.00 to C$60.00 and gave the company an “outperform” rating in a report on Friday. Finally, Desjardins raised their target price on Calian Group from C$59.00 to C$66.00 and gave the stock a “buy” rating in a research note on Thursday, November 27th. Six equities research analysts have rated the stock with a Buy rating, According to data from MarketBeat, the stock presently has a consensus rating of “Buy” and a consensus price target of C$74.83.

Calian Group Trading Up 6.7%

TSE:CGY opened at C$70.60 on Friday. The stock has a market capitalization of C$805.62 million, a price-to-earnings ratio of 30.96, a PEG ratio of 2.50 and a beta of 0.70. Calian Group has a 52 week low of C$37.70 and a 52 week high of C$71.92. The company has a quick ratio of 1.20, a current ratio of 1.29 and a debt-to-equity ratio of 39.54. The firm has a 50 day moving average of C$60.38 and a 200 day moving average of C$54.15.

Calian Group (TSE:CGY) last released its quarterly earnings results on Thursday, February 12th. The company reported C$1.03 earnings per share (EPS) for the quarter. The business had revenue of C$208.00 million for the quarter. Calian Group had a net margin of 1.50% and a return on equity of 3.37%. As a group, sell-side analysts anticipate that Calian Group will post 4.9475219 earnings per share for the current fiscal year.

Calian Group Dividend Announcement

The company also recently announced a quarterly dividend, which will be paid on Wednesday, March 11th. Stockholders of record on Wednesday, March 11th will be issued a dividend of $0.28 per share. This represents a $1.12 annualized dividend and a dividend yield of 1.6%. The ex-dividend date of this dividend is Wednesday, February 25th. Calian Group’s payout ratio is 49.12%.

Key Headlines Impacting Calian Group

Here are the key news stories impacting Calian Group this week:

• Positive Sentiment: Record Q1 results — Calian reported C$208M revenue (up ~12% YoY) with margin gains and C$1.03 EPS, and management signaled confident growth on the earnings call; this strengthens the growth narrative driving buying interest. Calian Delivers Record Q1 Revenue and Margin Gains
• Positive Sentiment: Multiple analyst target upgrades — Acumen (to C$85, Buy), Canaccord (to C$80), CIBC (to C$76) and Ventum (to C$82, Buy) raised price targets, signaling broad analyst optimism and providing upward catalyst for the stock. Analyst Ratings Roundup
• Positive Sentiment: Quarterly dividend declared — Board approved a C$0.28 quarterly dividend (annualized yield ~1.6%), with ex-dividend Feb 25 and record Mar 11; supports shareholder return profile and can attract income-minded buyers.
• Neutral Sentiment: Corporate governance update — Shareholders re‑elected the board and named Valerie Sorbie as Chair, which preserves leadership continuity but is unlikely to move the stock materially by itself. Shareholder Meeting Results
• Negative Sentiment: RBC’s moderate target bump to C$60 — Although RBC maintained an “outperform” stance, its target remains well below the current price, indicating at least one major analyst sees less upside and creating potential resistance or caution among some investors. RBC Target Update

About Calian Group

Calian Group Ltd operates through four segments namely Advanced Technologies, Health, Learning, and Information Technology. It generates maximum revenue from the Health segment. The company serves health, defence, security, aerospace, engineering, AgTech, and IT industries. Its Health segment includes Clinical Services; Nursing Services; Psychological Services and Medical Property Management. The Advanced Technologies segment includes Engineering Solutions and Services; Nuclear and Environmental Services; Satcom; DOCSIS; Electronics Design and Manufacturing and Agricultural Technology.